NICE recommends a weekly injection for treating growth failure in children
This recommendation comes from a pilot to develop simpler, faster evaluations for the appraisal of some treatments.
This recommendation comes from a pilot to develop simpler, faster evaluations for the appraisal of some treatments.
Hundreds more people eligible for breast cancer drug Enhertu as NICE recommends it for earlier stage disease, in final draft guidance.
NICE broadens nintedanib recommendation on chronic lung disease treatment.
Around 3,000 people could be eligible for a new life-extending combination therapy to treat rare forms of gastroesophageal cancer after NICE published final draft guidance today (24 November 2022).
Mobocertinib recommended as a treatment for a rare and aggressive form of lung cancer
Three treatments for COVID have been recommended in draft NICE guidance released today for public consultation.
Page 26 of 39